Doctor profile · Federal record
Dr. Emmalind Aponte, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · San Antonio, TX
- NPI 1699985002
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5206 Research Dr
San Antonio, TX 782405251
(210) 595-5300
fax (210) 614-8740 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- February 26, 2018
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Puerto Rico #14825
- Medicaid
- TX #297318203
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699985002. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
42,743
Distinct HCPCS
10
Medicare allowed
$290,994
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12,310 | 17 | $3 | |
J9025 |
Injection, azacitidine, 1 mg | 9,550 | 15 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 6,600 | 19 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,768 | 54 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,260 | 12 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,064 | 37 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 768 | 213 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 694 | 210 | $8 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 690 | 21 | $0 | |
80053 |
Blood test, comprehensive group of blood chemicals | 612 | 205 | $10 |
In context: peer comparison
Among 22 peers in this city , average services per provider: 1,021. This provider delivers 42× the peer median.Open Payments
Industry payments received
All-time total
$784
Transactions
11
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | 2 | $136.33 | |
| AstraZeneca Pharmaceuticals LP | 1 | $124.99 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $124.99 | |
| Genmab U.S., Inc. | 1 | $124.99 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $99.71 | |
| GENZYME CORPORATION | 1 | $85.65 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $40.30 | |
| Alexion Pharmaceuticals, Inc. | 1 | $30.00 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $17.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
984
Patients
255
Total drug cost
$532,681
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 348 | 102 | $10,132 |
| Ibandronate Sodium | Generic | 85 | 31 | $3,818 |
| Letrozole | Generic | 73 | 19 | $3,183 |
| Xarelto (Rivaroxaban) | Brand | 66 | 13 | $59,612 |
| Alendronate Sodium | Generic | 65 | 19 | $780 |
| Tamoxifen Citrate | Generic | 61 | 17 | $3,099 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 52 | 0 | $1,054 |
| Dexamethasone | Generic | 44 | 19 | $478 |
| Hydroxyurea | Generic | 38 | 0 | $1,745 |
| Eliquis (Apixaban) | Brand | 33 | 11 | $28,190 |
Hospital affiliations
Frequently asked questions
What is Dr. Emmalind Aponte's medical specialty?
Dr. Emmalind Aponte practices Hematology & Oncology Physician in San Antonio, TX.
Where does Dr. Emmalind Aponte practice?
Dr. Emmalind Aponte practices at 5206 Research Dr, San Antonio, TX 782405251. Office phone: 2105955300.
What is Dr. Emmalind Aponte's NPI?
Dr. Emmalind Aponte's National Provider Identifier (NPI) is 1699985002, issued by NPPES.
Does Dr. Emmalind Aponte accept Medicare assignment?
Yes. Dr. Emmalind Aponte accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Emmalind Aponte commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, azacitidine, 1 mg (HCPCS J9025); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.